Pronađeno: 1-4 / 4 radova

Autori: Mercadal Santiago

>> Filter: Samo Article i Review

Naslov Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial (Article)
Autori Davies Andrew  Merli Francesco  Mihaljevic Biljana S  Mercadal Santiago  Siritanaratkul Noppadol  Solal-Celigny Philippe  Boehnke Axel  Berge Claude  Genevray Magali  Zharkov Artem  Dixon Mark  Brewster Michael  Barrett Martin  MacDonald David 
Info LANCET HAEMATOLOGY, (2017), vol. 4 br. 6, str. E272-E282
Projekat F Hoffmann-La Roche
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study (Meeting Abstract)
Autori Davies Andrew J  Mihaljevic Biljana S  Mercadal Santiago  Mihaylov Georgi  Leppa Sirpa  Cotting Denise  Veenstra Klaas  Zharkov Artem  Dixon Mark  Barrett Martin  Macdonald David 
Info BLOOD, (2016), vol. 128 br. 22, str. -
Projekat Takeda Pharmaceutical Company Ltd; Mundipharma; GSKGlaxoSmithKline; Karyopharma; Roche Holding; Gilead Sciences; Bayer AG; Pfizer; JanssenJohnson & Johnson USAJanssen Biotech Inc; Mundipharma; CTI Bio Pharma
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Comparison of Subcutaneous and Intravenous Rituximab in the Maintenance Setting: Updated Safety Results of the Phase III Sabrina Study in Patients with Follicular Lymphoma (Meeting Abstract)
Autori Davies A  Mihaljevic Biljana S  Mercadal Santiago  Mihaylov G  Leppa S  Cotting D  Munoz FJ  Veenstra K  Berthillon N  Barrett M  MacDonald D 
Info HAEMATOLOGICA, (2015), vol. 100 br. , Suppl. 1, str. 271-272
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Subcutaneous Rituximab and Chemotherapy Achieves Similar Overall Response Rates to Intravenous Rituximab in First-Line Follicular Lymphoma: Efficacy and Safety Results of the Phase Iii Sabrina Study (Meeting Abstract)
Autori Davies A  Merli Francesco  Mihaljevic Biljana S  Mercadal Santiago  Solal-Celigny Philippe  Boehnke Axel  Berge Claude  Cambon N  Macgregor L  Brewster M  Barrett M  MacDonald D 
Info HAEMATOLOGICA, (2014), vol. 99 br. , Suppl. 1, str. 225-225
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX